New immunochemical fecal occult blood test with two-consecutive stool sample testing is a cost-effective approach for colon cancer screening: Results of a prospective multicenter study in Chinese patients

International Journal of Cancer

Volumn 118, Issue 12, 2006, Pages 3078-3083

  Li, Shirong ^a   Wang, Huahong ^b   Hu, Jichun ^c   Li, Nan ^d   Liu, Yulan ^e   Wu, Zitao ^a   Zheng, Yue ^b   Wang, Honghua ^c   Wu, Kai ^d   Ye, Hui ^e   Rao, Jianyu ^f,g  

^a CHINESE PLA GENERAL HOSPITAL   (China)

^b PEKING UNIVERSITY FIRST HOSPITAL   (China)

^c Beijing Haidian Hospital   (China)

^d 309TH HOSPITAL OF PLA   (China)

^e Ministry of Education Beijing   (China)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Colon cancer; Fecal occult blood test; Screening

Indexed keywords

GUAIAC;

ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER SCREENING; CHINESE; CLINICAL TRIAL; COLON CANCER; COLONOSCOPY; COST EFFECTIVENESS ANALYSIS; DEVICE; FECES ANALYSIS; FEMALE; HIGH RISK PATIENT; HUMAN; IMMUNOCHEMISTRY; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OCCULT BLOOD; PRIORITY JOURNAL; PROSPECTIVE STUDY; SAMPLING;

ADENOMA; ADULT; AGED; CHINA; COLONIC NEOPLASMS; COLONOSCOPY; COST-BENEFIT ANALYSIS; FEMALE; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; OCCULT BLOOD; SENSITIVITY AND SPECIFICITY;

EID: 33646427203     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.21774     Document Type: Article

References (19)

1. Gao YT. Evaluation and significance of sampling investigation for malignant tumors in China from 1990 to 1992. Chin J Oncol 2000; 22:263-4.
2. Lu YM, Gu F, Li SR, Chu ZM. Significance of clinical screening colonoscopy and colonoscopic polypectomy with pathology in diagnosis of early colon cancer. Chin J Dig Endoscope 1997;14:222-4.
3. Li SR. A multi-center GI Research group of Beijing area: evaluation of mass screening for colorectal cancer with "sequential fecal occult blood test" in an symptomatic population-the results of colorectal cancer screening for the population with 102,800 asymptomatic people. Chin J Oncol 1993;15:230-2.
4. Jorgensen OD, Kronborg O, Fenger C. A randomized study of screening for colorectal cancer using fecal occult blood testing: results after 13 years and seven biennial screening rounds. Gut 2002;50:29-32.
5. Mandel JS, Church TR, Bond JH, Ederer F, Geisser MS, Mongin SJ, Snover DC, Schuman LM. The effect of fecal occult-blood screening on the incidence of colorectal cancer. N England J Med 2000;343: 1603-7.
6. Kronborg O, Fenger C, Olsen J, Jorgensen OD, Sondergaard O. Randomized study of screening for colorectal cancer with fecal occult blood test. Lancet 1996;348:1467-71.
7. Hardcastle JD, Chamberlain JO, Robinson MH, Moss SM, Amar SS, Balfour TW, James PD, Maugham CM. Randomized controlled trial of fecal occult blood screening for colorectal cancer. Lancet 1996; 348:1472-7.
8. Smith RA, Mettlin CJ, Davis KJ, Eyre H. American Cancer Society guidelines for the early detection of cancer. CA Cancer J Clin 2000: 50:34-49.
9. Ouyang DL, Chen JJ, Getzenberg RH, Schoen RE. Noninvasive testing for colorectal cancer: a review. Am J Gastroenterol 2005;100: 1393-403.
10. Li SR, Liu DQ, Yu YW, Gu YQ, Wang GY, Lin M, Gao G. Evaluation of serial fecal occult blood for the mass screening of colorectal cancer. Chin Geron J Med 1990;9:152-4.
11. Li SR, Nie ZH, Li N, Li JX, Zheng P, Yang ZX, Mu SC, Du YP, Hu JC, Yuan SY, Qu HT, Zhang TC, et al. Colorectal cancer for the natural population of Beijing with sequential fecal occult blood test: a multi-center study. Chin Med J 2003;116:200-2
12. Li SR, Tian SL, Wu ZT, Han Y, Sheng JQ, Gao G, Xia CH, Cao JB, Chen ZM, Wang ZH, Li YJ. Application of sequential fecal occult blood test in consecutive screenings of colorectal carcinoma for natural population. World Chin J Dig 2004;12:137-9.
13. Mandel JS, Bond JH, Church TR, Snover DC, Bradley GM, Schuman LM, Ederer F. Reducing mortality from colorectal cancer by screening for fecal occult blood. N Engl J Med 1993;328:1365-71.
14. Young GP, St. John DJ, Winawer SJ, Rozen P, WHO (World Health Organization), OMED (World Organization for Digestive Endoscopy). Choice of fecal occult blood tests for colorectal cancer screening: recommendations based on performance characteristics in population studies: a WHO (World Health Organization) and OMED (World Organization for Digestive Endoscopy) report. Am J Gastroenterol 2002;97:2499-507.
15. Saito H. Screening for colorectal cancer by immunochemical fecal occult blood testing. Jpn J Cancer Res 1996;87:1011-24.
16. Greenberg PD, Bertario L, Gnauck R, Kronborg O, Hardcastle JD, Epstein MS, Sadowski D, Sudduth R, Zuckerman GR, Rockey DC. A prospective multicenter evaluation of new fecal occult blood tests in patients undergoing colonoscopy. Am J Gastroenterol 2000;95: 1331-8.
17. Wong WM, Lam SK, Chetmg KL. Evaluation of an automated immunochemical fecal occult blood test for colorectal neoplasia in a Chinese population. Cancer 2003;97:2420-4.
18. Wong BC, Wong WM, Cheung KL, Tung TS, Rozen P, Young GP, Chu KW, Hu J, Law WL, Tung HM, Hu WH, Chan CK, et al. A sensitive guaiac fecal occult blood test is less useful than an immunochemical test for colorectal cancer screening in a Chinese population. Aliment Pharmacol Ther 2003;18:96-6.
19. Williams AR, Balasoori BAW, Day DW. Polyps and cancer of the large bowel: an autopsy survey. Gut 1982;123:835-42.